{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:08:35Z","timestamp":1793725715231,"version":"4.6.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,2,21]],"date-time":"2011-02-21T00:00:00Z","timestamp":1298246400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1471-2210-11-2","type":"journal-article","created":{"date-parts":[[2011,2,22]],"date-time":"2011-02-22T07:21:03Z","timestamp":1298359263000},"source":"Crossref","is-referenced-by-count":32,"title":["Effects of rasagiline, its metabolite aminoindan and selegiline on glutamate receptor mediated signalling in the rat hippocampus slice in vitro"],"prefix":"10.1186","volume":"11","author":[{"given":"W","family":"Dimpfel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JA","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,2,21]]},"reference":[{"key":"779_CR1","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.neulet.2003.10.067","volume":"355","author":"O Bar-Am","year":"2004","unstructured":"Bar-Am O, Amit T, Youdim MBH: Contrasting neuroprotective and neurotoxic actions of respective metabolites of anti-Parkinson drugs rasagiline and selegiline. Neuroscience Lett. 2004, 355: 169-172. 10.1016\/j.neulet.2003.10.067.","journal-title":"Neuroscience Lett"},{"key":"779_CR2","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1111\/j.1471-4159.2007.04777.x","volume":"103","author":"O Bar-Am","year":"2007","unstructured":"Bar-Am O, Amit T, Youdim MBH: Aminoindan and hydroxyaminoindan, metabolites of rasagiline and ladostigil, respectively, exert neuroprotective properties in vitro. J Neurochem. 2007, 103: 500-8. 10.1111\/j.1471-4159.2007.04777.x.","journal-title":"J Neurochem"},{"key":"779_CR3","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1159\/000319947","volume":"62","author":"W Dimpfel","year":"2010","unstructured":"Dimpfel W, Hoffmann JA: Electropharmacograms of Rasagiline, Its Metabolite Aminoindan and Selegiline in the Freely Moving Rat. Neuropsychobiol. 2010, 62: 213-220. 10.1159\/000319947.","journal-title":"Neuropsychobiol"},{"key":"779_CR4","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/j.1749-6632.2001.tb03656.x","volume":"939","author":"MB Youdim","year":"2001","unstructured":"Youdim MB, Wadia A, Tatton W, Weinstock M: The anti-Parkinson drug rasagiline and its cholinesterase inhibitor derivatives exert neuroprotection unrelated to MAO inhibition in cell culture and in vivo. Ann N Y Acad Sci. 2001, 939: 450-8. 10.1111\/j.1749-6632.2001.tb03656.x.","journal-title":"Ann N Y Acad Sci"},{"key":"779_CR5","first-page":"113","volume":"112","author":"O Bar-Am","year":"2009","unstructured":"Bar-Am O, Winreb O, Amit T, Youdim MBH: The neuroprotective mechanism of 1-(R))-aminoindan, the major metabolite of the anti-Parkinsonian drug rasagiline. J Neurochem. 2009, 112: 113-7.","journal-title":"J Neurochem"},{"key":"779_CR6","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.brainresrev.2004.12.027","volume":"48","author":"S Mandel","year":"2005","unstructured":"Mandel S, Weinreb O, Amit T, Youdim MBH: Mechanism of neuroprotective action of the anti-Parkinson drug rasagiline and its derivatives. Brain Res Rev. 2005, 48: 379-87. 10.1016\/j.brainresrev.2004.12.027.","journal-title":"Brain Res Rev"},{"key":"779_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev.ne.03.030180.000245","volume":"3","author":"G Lynch","year":"1980","unstructured":"Lynch G, Schubert P: The use of in-vitro brain slices for multidisciplnary studies of synaptic function. Ann Rev Neurosci. 1980, 3: 1-22. 10.1146\/annurev.ne.03.030180.000245.","journal-title":"Ann Rev Neurosci"},{"key":"779_CR8","volume-title":"Plenum Press New York, London","author":"R Dingledine","year":"1984","unstructured":"Dingledine R: Brain Slices. Plenum Press New York, London. 1984"},{"key":"779_CR9","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.expneurol.2008.03.006","volume":"212","author":"H Zhang","year":"2008","unstructured":"Zhang H, Schools GP, Lei T, Wang W, Kimelberg HK, Zhou M: Resveratrol attenuates early pyramidal neuron excitability impairment and death in acute rat hippocampal slices caused by oxygen-glucose deprivation. Exp Neurol. 2008, 212: 44-52. 10.1016\/j.expneurol.2008.03.006.","journal-title":"Exp Neurol"},{"key":"779_CR10","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/0924-977X(94)90009-4","volume":"4","author":"W Dimpfel","year":"1994","unstructured":"Dimpfel W, Dalhoff B, Hofmann W, Schl\u00fcter G: Electrically evoked potentials in the rat hippocampus slice in the presence of aminophylline alone and in combination with quinolones. European Neuropsychopharmacology. 1994, 4: 151-56. 10.1016\/0924-977X(94)90009-4.","journal-title":"European Neuropsychopharmacology"},{"key":"779_CR11","first-page":"523","volume":"1","author":"W Dimpfel","year":"1996","unstructured":"Dimpfel W: Effect of thioctic acid on pyramidal cell responses in the rat hippocampus in vitro. Eur J Med Res. 1996, 1: 523-527.","journal-title":"Eur J Med Res"},{"key":"779_CR12","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1128\/AAC.35.6.1142","volume":"35","author":"W Dimpfel","year":"1991","unstructured":"Dimpfel W, Sp\u00fcler M, Dalhoff A, Hoffmann W, Schl\u00fcter G: Hippocampal activity in the presence of quinolones and fenbufen in-vitro. Antimicrobial Agents and Chemotherapy. 1991, 35: 1142-1146.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"779_CR13","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/0165-0270(79)90021-9","volume":"1","author":"HL Haas","year":"1979","unstructured":"Haas HL, Schaerer B, Vosmansky M: A simple perfusion chamber for the study of nervous tissue slices in vitro. J Neurosci Methods. 1979, 1: 323-5. 10.1016\/0165-0270(79)90021-9.","journal-title":"J Neurosci Methods"},{"key":"779_CR14","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/0006-8993(85)91004-2","volume":"345","author":"SJ Schiff","year":"1985","unstructured":"Schiff SJ, Somjen GG: The Effects of Temperature on Synaptic Transmission in Hippocampal Tissue Slices. Brain Research. 1985, 345: 279-284. 10.1016\/0006-8993(85)91004-2.","journal-title":"Brain Research"},{"key":"779_CR15","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1745-7254.2006.00259.x","volume":"27","author":"ZJ Wang","year":"2006","unstructured":"Wang ZJ, Li GM, Tang WL, Yin M: Neuroprotective effects of stearic acid against toxicity of oxygen\/glucose deprivation or glutamate on rat cortical or hippocampal slices. Acta Pharmacol Sin. 2006, 27: 145-50. 10.1111\/j.1745-7254.2006.00259.x.","journal-title":"Acta Pharmacol Sin"},{"key":"779_CR16","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1021\/jm00172a036","volume":"33","author":"RD Allan","year":"1990","unstructured":"Allan RD, Hanrahan JR, Hambley TW, Johnston GA, Mewett KN, Mitrovic AD: Synthesis and activity of a potent N-methyl-D-aspartic acid agonist, trans-1-aminocyclobutane-1,3-dicarboxylic acid, and related phosphonic and carboxylic acids. J Med Chem. 1990, 33: 2905-10.1021\/jm00172a036.","journal-title":"J Med Chem"},{"key":"779_CR17","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1523\/JNEUROSCI.14-06-03881.1994","volume":"14","author":"LA Wong","year":"1994","unstructured":"Wong LA, Mayer ML, Jane DE, Watkins JC: Willardiines differentiate agonist binding sites for kainate-versus AMPA-preferring glutamate receptors in DRG and hippocampal neurons. J Neurosci. 1994, 14: 3881-","journal-title":"J Neurosci"},{"key":"779_CR18","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/0028-3908(94)00157-N","volume":"34","author":"LM Hawkins","year":"1995","unstructured":"Hawkins LM, Beaver KM, Jane DE, Taylor PM, Sunter DC, Roberts PJ: Binding of the new radioligand (S)-[3H]AMPA to rat brain synaptic membranes: effects of a series of structural analogues of the non-NMDA receptor agonist willardiine. Neuropharmacology. 1995, 34: 405-10.1016\/0028-3908(94)00157-N.","journal-title":"Neuropharmacology"},{"key":"779_CR19","doi-asserted-by":"publisher","first-page":"3645","DOI":"10.1021\/jm9702387","volume":"40","author":"DE Jane","year":"1997","unstructured":"Jane DE, Hoo K, Kamboj R, Deverill M, Bleakman D, Mandelzys A: Synthesis of willardiine and 6-azawillardiine analogs: pharmacological characterization on cloned homomeric human AMPA and kainate receptor subtypes. J Med Chem. 1997, 40: 3645-10.1021\/jm9702387.","journal-title":"J Med Chem"},{"key":"779_CR20","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1021\/jm9607212","volume":"40","author":"L Matzen","year":"1997","unstructured":"Matzen L, Engesgaard A, Ebert B, Didriksen M, Fr\u00f8lund B, Krogsgaard-Larsen P, Jaroszewski JWA: PA receptor agonists: synthesis, protolytic properties, and pharmacology of 3-isothiazolol bioisosteres of glutamic acid. J Med Chem. 1997, 40: 520-10.1021\/jm9607212.","journal-title":"J Med Chem"},{"key":"779_CR21","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/39315","volume":"389","author":"VR Clarke","year":"1997","unstructured":"Clarke VR, Ballyk BA, Hoo KH, Mandelzys A, Pellizzari A, Bath CP, Thomas J, Sharpe EF, Davies CH, Ornstein PL, Schoepp DD, Kamboj RK, Collingridge GL, Lodge D, Bleakman D: A hippocampal GluR5 kainate receptor regulating inhibitory synaptic transmission. Nature. 1997, 389: 599-10.1038\/39315.","journal-title":"Nature"},{"key":"779_CR22","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1016\/S0014-2999(99)00456-2","volume":"378","author":"RX Moldrich","year":"1999","unstructured":"Moldrich RX, Cheung NS, Pascoe CJ, Beart PM: Excitotoxic injury profiles of low-affinity kainate receptor agonists in cortical neuronal cultures. Eur J Pharmaocol. 1999, 378: R1-10.1016\/S0014-2999(99)00456-2.","journal-title":"Eur J Pharmaocol"},{"key":"779_CR23","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.neuropharm.2004.02.010","volume":"46","author":"RM Kaminski","year":"2004","unstructured":"Kaminski RM, Banerjee M, Rogawski MA: Topiramate selectively protects against seizures induced by ATPA, a GluR5 kainate receptor agonist. Neuropharmacology. 2004, 46: 1097-10.1016\/j.neuropharm.2004.02.010.","journal-title":"Neuropharmacology"},{"key":"779_CR24","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/0014-2999(90)90462-F","volume":"186","author":"AJ Irving","year":"1990","unstructured":"Irving AJ, Schofield JG, Watkins JC, Sunter DC, Collingridge GL: 1 S,3R-ACPD stimulates and L-AP3 blocks Ca2+ mobilization in rat cerebellar neurons. Eur J Pharmaocol. 1990, 186: 363-5. 10.1016\/0014-2999(90)90462-F.","journal-title":"Eur J Pharmaocol"},{"key":"779_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0028-3908(94)00129-G","volume":"34","author":"JP Pin","year":"1995","unstructured":"Pin JP, Duvoisin R: The metabotropic glutamate receptors: structure and functions. Neuropharmacology. 1995, 34: 1-10.1016\/0028-3908(94)00129-G.","journal-title":"Neuropharmacology"},{"key":"779_CR26","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1021\/jm00009a001","volume":"38","author":"T Kn\u00f6pfel","year":"1995","unstructured":"Kn\u00f6pfel T, Kuhn R, Allgeier H: Metabotropic glutamate receptors: novel targets for drug development. J Med Chem. 1995, 38: 1417-","journal-title":"J Med Chem"},{"key":"779_CR27","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1111\/j.1471-4159.2008.05330.x","volume":"105","author":"W Zhu","year":"2008","unstructured":"Zhu W, Xie W, Pan T, Jankovic J, Li J, Youdim MBH, Le W: Comparison of neuroprotective and neurorestorative capabilities of rasagiline and selegiline against lactacystin-induced nigrostriatal dopaminergic degeneration. J Neurochem. 2008, 105: 1970-8. 10.1111\/j.1471-4159.2008.05330.x.","journal-title":"J Neurochem"},{"key":"779_CR28","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0014-2999(01)01548-5","volume":"434","author":"S Abu-Rava","year":"2002","unstructured":"Abu-Rava S, Tabakman R, Blaugrund E, Trembovier V, Lazarovici P: Neuroprotective and neurotoxic effects of monoamine-oxydase-B inhibitors and derived metabolites under ischemia in PC12 cells. Eur J Pharmacol. 2002, 434: 109-16. 10.1016\/S0014-2999(01)01548-5.","journal-title":"Eur J Pharmacol"},{"key":"779_CR29","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1096\/fj.05-3794fje","volume":"19","author":"O Bar-Am","year":"2005","unstructured":"Bar-Am O, Weinreb O, Amit T, Youdim MBH: Regulation of Bcl-2 familiy proteins, neurotrophic factors, and APP processing in the neurorescue activity of propargylamine. FASEB J. 2005, 19: 1899-901.","journal-title":"FASEB J"},{"key":"779_CR30","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s12640-009-9064-7","volume":"16","author":"X-M Ou","year":"2010","unstructured":"Ou X-M, Lu D, Johnson C, Chen K, Youdim MBH, Rajkowska G, Shih JC: Glyceraldehyde-3-phosphate dehydrogenase-Monoamine oxidase B-mediated cell Death-induced by Ethanol is prevented by Rasagiline and 1-R-Aminoindan. Neurotox Res. 2010, 16: 148-159. 10.1007\/s12640-009-9064-7.","journal-title":"Neurotox Res"},{"key":"779_CR31","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/BF03033787","volume":"2","author":"W Danysz","year":"2000","unstructured":"Danysz W, Parsons CG, Mobius HJ, Stoffler A, Quack G: Neuroprotective and symptomatological action of memantine relevant for Alzheimers's disease-a unified glutamatergic hypothesis o the mechanism of action. Neurotox Res. 2000, 2: 85-97. 10.1007\/BF03033787.","journal-title":"Neurotox Res"},{"key":"779_CR32","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.expneurol.2005.08.017","volume":"196","author":"F Bibbiani","year":"2005","unstructured":"Bibbiani F, Oh JD, Kielaite A, Collins MA, Smith C, Chase TN: Combined blockade of NMDA and AMPA glutamate receptors reduces levo-dopa induced motor complications in animal models of PD. Exp Neurol. 2005, 196: 422-9. 10.1016\/j.expneurol.2005.08.017.","journal-title":"Exp Neurol"},{"key":"779_CR33","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.nbd.2003.07.003","volume":"14","author":"F Calon","year":"2003","unstructured":"Calon F, Rajput AH, Hornykiewicz O, Bedard PJ, Paolo TDi: Levo-dopa induced motor complications are associated with alterations of glutamate receptors in Parkinson's disease. Neurobiol Diss. 2003, 14: 404-16. 10.1016\/j.nbd.2003.07.003.","journal-title":"Neurobiol Diss"},{"key":"779_CR34","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.pharmthera.2004.04.001","volume":"102","author":"PJ Hallet","year":"2004","unstructured":"Hallet PJ, Standaert DG: Rationale for and use of NMDA receptor antagonists in Parkinson's disease. Pharmaco Ther. 2004, 102: 155-74. 10.1016\/j.pharmthera.2004.04.001.","journal-title":"Pharmaco Ther"},{"key":"779_CR35","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.brainresbull.2005.12.009","volume":"69","author":"A Dekundy","year":"2006","unstructured":"Dekundy A, Pietraszek M, Schaefer D, Cency MA, Danysz W: Effects of group I metabotropic glutamate receptors blockade in experimental models of Parkinson's disease. Brain Res Bull. 2006, 69: 318-26. 10.1016\/j.brainresbull.2005.12.009.","journal-title":"Brain Res Bull"},{"key":"779_CR36","doi-asserted-by":"publisher","first-page":"3241","DOI":"10.1111\/j.1460-9568.2005.04488.x","volume":"22","author":"K Kaneda","year":"2005","unstructured":"Kaneda K, Tachybana Y, Imanishi M, Kita H, Shigemoto R, Nambu A, Takada M: Down-regulation of metabotropic glutamate receptor 1alpha in globus pallidus and substantia nigra of parkinson monkeys. Eur J Neurosci. 2005, 22: 3241-54. 10.1111\/j.1460-9568.2005.04488.x.","journal-title":"Eur J Neurosci"},{"key":"779_CR37","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3233\/JAD-2007-11113","volume":"11","author":"CP Jacob","year":"2007","unstructured":"Jacob CP, Koutsilleri E, Bartl J, Neuen-Jacob E, Arzberger T, Zander N, Ravid R, Roggendorf W, Riederer P, Gr\u00fcnblatt E: Alterations in expression of glutamatergic transporters and receptors in sporadic Alzheimer's disease. J Alzheimers Dis. 2007, 11: 97-116.","journal-title":"J Alzheimers Dis"},{"key":"779_CR38","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.expneurol.2007.10.008","volume":"210","author":"K Parameshwaran","year":"2008","unstructured":"Parameshwaran K, Dhanasekaran M, Suppiramaniam V: Amyloid beta peptides and glutamatergic synaptic dysregulation. Exp Neurol. 2008, 210: 7-13. 10.1016\/j.expneurol.2007.10.008.","journal-title":"Exp Neurol"},{"key":"779_CR39","doi-asserted-by":"publisher","first-page":"4583","DOI":"10.2174\/138161206778522092","volume":"12","author":"R Planells-Cases","year":"2006","unstructured":"Planells-Cases R, Lerma J, Ferrer-Montiel A: Pharmacological interventions at ionotropic glutamate receptor complexes. Curr Pharma Des. 2006, 12: 4583-96. 10.2174\/138161206778522092.","journal-title":"Curr Pharma Des"}],"container-title":["BMC Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2210-11-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2210-11-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2210-11-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T06:13:38Z","timestamp":1548137618000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1186\/1471-2210-11-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,21]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["779"],"URL":"https:\/\/doi.org\/10.1186\/1471-2210-11-2","relation":{},"ISSN":["1471-2210"],"issn-type":[{"value":"1471-2210","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,21]]},"article-number":"2"}}